Nakamura H, Said J W, Miller C W, Koeffler H P
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.
Blood. 1993 Aug 1;82(3):920-6.
p53 mutations are found in a variety of neoplasia. B-immunoblastic lymphoma (BIBL) is a rapidly progressive, aggressive lymphoma. As patients with acquired immunodeficiency syndrome (AIDS) live longer, BIBL is becoming an increasing problem. We asked three questions in our study. What is the frequency of p53 mutations in BIBL? Is it more frequent in patients with AIDS? Can immunohistochemical staining of lymph nodes for expression of p53 substitute for mutational analysis of p53 to detect lymphomas with mutated p53? Exons 5, 6, 7, 8 of the p53 gene (hot-spots for mutations) were amplified and examined for mutations by single-strand conformation polymorphism (SSCP) analysis. Altered migration was observed in 7 of 52 BIBL samples. Of these, 4 of 25 were from individuals infected with human immunodeficiency virus (HIV) and 3 of 27 were not infected with HIV. Direct sequencing of amplified material confirmed the presence of mutations in exons 5, 7, 8 of p53. A total of 26 BIBL as well as other lymphoma/leukemia samples, stained strongly by immunohistochemistry with three antibodies directed against human p53. Five of 6 BIBL samples with p53 mutations stained strongly for p53, but 20 lymphoma samples with no detectable p53 mutations also stained strongly for p53. Of note, however, 10 hyperplastic, nonmalignant lymph nodes from individuals either infected or not infected with HIV had negligible staining for p53 protein. In conclusion, p53 mutations occur in about 14% BIBL samples; the frequency of p53 mutations in BIBL in individuals with and without AIDS was similar. Positive p53 immunohistochemistry did not correlate with detectable p53 mutations in the same tissue, but positive immunohistochemical staining for p53 was only found in neoplastic lymph nodes. This latter finding provides a strong warning that p53 immunochemistry with available reagents cannot be used to determine which tumors have mutations of p53.
p53突变见于多种肿瘤。B免疫母细胞淋巴瘤(BIBL)是一种进展迅速、侵袭性强的淋巴瘤。随着获得性免疫缺陷综合征(AIDS)患者生存期延长,BIBL正成为一个日益突出的问题。我们在研究中提出了三个问题。BIBL中p53突变的频率是多少?在AIDS患者中是否更常见?对淋巴结进行p53表达的免疫组化染色能否替代p53突变分析来检测p53突变的淋巴瘤?对p53基因的第5、6、7、8外显子(突变热点)进行扩增,并通过单链构象多态性(SSCP)分析检测突变。在52个BIBL样本中有7个观察到迁移改变。其中,25个样本中有4个来自感染人类免疫缺陷病毒(HIV)的个体,27个未感染HIV的样本中有3个。对扩增产物进行直接测序证实了p53第5、7、8外显子中存在突变。共有26个BIBL以及其他淋巴瘤/白血病样本,用三种针对人p53的抗体进行免疫组化染色时呈强阳性。6个有p53突变的BIBL样本中有5个p53染色呈强阳性,但20个未检测到p53突变的淋巴瘤样本p53染色也呈强阳性。然而,值得注意的是,10个来自感染或未感染HIV个体的增生性、非恶性淋巴结p53蛋白染色可忽略不计。总之,约14%的BIBL样本中存在p53突变;有和没有AIDS的个体中BIBL的p53突变频率相似。p53免疫组化阳性与同一组织中可检测到的p53突变不相关,但p53免疫组化阳性仅见于肿瘤性淋巴结。后一发现强烈警示,现有的试剂进行p53免疫化学不能用于确定哪些肿瘤存在p53突变。